Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
03/2002
03/27/2002CN1342137A N2 phenylamidine derivatives
03/27/2002CN1341594A Substituted pyrrolidone, thiazolidone or oxazolidone as herbicide
03/27/2002CN1081632C Form III crystalline (R-(R*,R*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
03/27/2002CN1081631C N-methyl-N[(1S)-1-phenyl-2-(2S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide
03/27/2002CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists
03/27/2002CA2321348A1 Aromatic derivatives with hiv integrase inhibitory properties
03/26/2002US6362371 β2- adrenergic receptor agonists
03/26/2002US6362231 Calcium receptor active compounds
03/26/2002US6362230 Alzheimer's disease
03/26/2002US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use
03/26/2002US6362183 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/26/2002US6362177 Cyclic amine derivatives and their use as drugs
03/26/2002CA2041588C Cyclohexenone oxime ethers, their preparation, intermediates for their preparation and their use as herbicides
03/21/2002WO2002022694A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
03/21/2002WO2002022592A2 Substituted urea neuropeptide y y5 receptor antagonists
03/21/2002WO2002022580A1 Antibacterials mutilins
03/21/2002WO2002022575A1 Amidine inhibitors of serine proteases
03/21/2002WO2002022572A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
03/21/2002WO2002022554A1 Process and intermediates
03/21/2002WO2002022551A1 Derivatives of naphthalene with comt inhibiting activity
03/21/2002WO2002022549A1 Process for the removal of nitrobenzenesulfonyl
03/21/2002WO2001077091A3 Ns5b hcv polymerase inhibitors
03/21/2002WO2001034135A3 Oncolytic combinations for the treatment of cancer
03/21/2002US20020035270 Amidation, cyclization using butyrolactone or hydroxybutyric acid and alkylamine
03/21/2002US20020035136 Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors
03/21/2002US20020035127 Phenylalanine derivatives
03/21/2002US20020035104 Integrin receptor inhibitors
03/21/2002US20020035103 For diseases or conditions caused by or exacerbated by histamine-3 receptor activity
03/21/2002US20020035072 Method for enhancing mutant enzyme activities in lysosomal storage disorders
03/21/2002US20020035065 Selective MMP inhibitors having reduced side-effects
03/21/2002US20020034709 Material for photo-alignment layer, photo-alignment layer and method of manufacturing the same
03/21/2002DE10045530A1 Kombinatorische Herstellung einer Substanzbibliothek unter Abtrennung einer zwitterionischen Verbindung durch Fällung Combinatorial preparation of a compound library with removal of a zwitterionic compound by precipitation
03/21/2002CA2422055A1 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
03/21/2002CA2422013A1 Substituted urea neuropeptide y y5 receptor antagonists
03/21/2002CA2421054A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
03/20/2002EP1188746A1 Material for photo-alignment layer, photo-alignment layer and method of manufacturing the same
03/20/2002EP1188745A1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
03/20/2002EP1188744A1 Process for producing 1H-3-aminopyrrolidine and derivatives thereof
03/20/2002EP1188732A2 Combinatorial synthesis of a chemical library involving the separation of a zwitterionic compound by precipitation
03/20/2002EP1188439A2 Cell differentiation induction with mevalonate and mevalonolactone derivatives
03/20/2002EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/20/2002EP0628077B1 Humanised antibodies directed against a33 antigen
03/20/2002CN1341098A W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
03/20/2002CN1341094A Monoamine reuptake inhibitors for treatment of CNS disorders
03/20/2002CN1340592A Material for light-oriented film, light-oriented film and its manufacture method
03/20/2002CN1081185C N-arylthiohydrazone derivatives as insecticidal and acaricidal agents
03/19/2002US6359151 Use as pesticides.
03/19/2002US6359147 Reactions catalyzed by chromium (III) carboxylates
03/19/2002US6358995 Carboxylic acid derivatives having fused rings
03/19/2002US6358887 2-Phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides
03/19/2002US6358689 Detection of markers in nascent proteins
03/19/2002US6358634 Nitrogen-containing heterocyclic compound, organic light-emitting device material and organic light-emitting device
03/19/2002CA2079548C Carbamate derivatives of 4-amino-3- isoxazolidinones, 3-amino-1- hydroxypyrrolidin-2-ones and 1-amino-1- cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments
03/19/2002CA2050331C Ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
03/14/2002WO2002020526A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
03/14/2002WO2002020485A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/14/2002WO2001070757A3 Thioketals and thioethers for inhibiting the expression of vcam-1
03/14/2002WO2001060781A3 Diphenyl compounds, formulations and uses thereof
03/14/2002WO2001055130A3 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
03/14/2002US20020032334 Oligomers and polymers of di-substituted cyclic imino carboxylic acids
03/14/2002US20020032237 Antipicornaviral compounds, compositions containing them, and methods for their use
03/14/2002US20020032230 Dihydrofuranonyl- or dihydropyrrolinonyl-phenyl compounds containing substituted thio, sulfoxide or sulfonyl groups
03/14/2002US20020032221 Treatment of HIV mediated diseases.
03/14/2002US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
03/14/2002DE10040901A1 Neue Phenyl- und Phenylalkyl-substituierte Ethanolamine und Ethylendiamine New phenyl and phenylalkyl substituted ethanolamines and ethylenediamines
03/14/2002CA2421506A1 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
03/14/2002CA2417177A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/13/2002EP1186603A2 Processes for preparing endothelin antagonists
03/13/2002EP1185522A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions containing them
03/13/2002EP1185512A2 INHIBITORS OF FACTOR Xa
03/13/2002EP1185511A2 Inhibitors of factor xa
03/13/2002EP1185509A2 INHIBITORS OF FACTOR Xa
03/13/2002EP1185508A2 Inhibitors of factor xa
03/13/2002EP1185493A1 Quinones for treatment of diseases
03/13/2002EP1185264A1 Process for the production of amorphous atorvastatin calcium
03/13/2002EP0975219B1 Fungicide active substance combinations
03/13/2002CN1340058A Compounds which inhibit leukocyte adhesion mediated by VLA-4
03/13/2002CN1340040A Stabilised compositions of 0-and N-vinyl compounds and the use of ammonium salts as stabilisers
03/13/2002CN1080719C Substituted 1H-3-aryl-pyrrolidine-2,4-diones derivatives
03/12/2002US6355810 Multibinding inhibitors of HMG-CoA reductase
03/12/2002US6355807 Multistep process including cyanomethylation, reduction, cyclization, deprotection, oxidation, olefination and amidation
03/12/2002US6355805 β3-adrenergic receptor agonists
03/12/2002US6355673 Substituted diaminocarboxylic acids
03/12/2002US6355664 Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
03/12/2002US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents
03/12/2002US6355655 Treating a cognitive disorder, a neuro-degenerative disorder; age-related dementia; age-induced memory impairment; a movement disorder, attention deficit disorder; attention deficit hyperactivity disorder; psychosis; cognitive deficits
03/12/2002US6355632 Naphthyl compounds, intermediates, compositions, and methods
03/12/2002CA2022975C Arylpyrrole insecticidal, acaricidal and nematicidal agents and methods
03/07/2002WO2002018336A1 Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine
03/07/2002WO2002018334A2 Sodium channel modulators
03/07/2002WO2002018321A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
03/07/2002WO2002018318A1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives
03/07/2002WO2002017925A1 Non-symmetric tripyrrannes in the synthesis of novel macrocycles
03/07/2002WO2002017712A2 Disubstituted benzenes as insecticides
03/07/2002WO2001085680A3 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
03/07/2002WO2001070684A3 Peptidomimetic ligands for cellular receptors and ion channels
03/07/2002WO2001068645A3 N-cyanomethylcarboxamides and their use as protease inhibitors
03/07/2002WO2001068033A3 Il-8 receptor antagonists
03/07/2002WO2001055131A3 Prodigiosin-derivatives as neoplastic and anti-viral agents
03/07/2002WO2001034596A3 Pyrrolecarbonylimino derivatives as naaladase inhibitors